Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13,025.71% | -50.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13,025.71% | -50.43% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 13,025.71% | -50.43% | |||
| SG&A Expenses | 10.84% | 13.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.60% | -7.42% | |||
| Operating Income | 811.45% | 2.06% | |||
| Income Before Tax | 1,110.36% | 2.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1,087.91% | -4.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,087.91% | -4.42% | |||
| EBIT | 811.45% | 2.06% | |||
| EBITDA | 826.59% | 3.44% | |||
| EPS Basic | 1,091.57% | -4.05% | |||
| Normalized Basic EPS | 1,155.46% | 18.42% | |||
| EPS Diluted | 1,085.51% | -4.05% | |||
| Normalized Diluted EPS | 1,149.02% | 18.42% | |||
| Average Basic Shares Outstanding | -0.37% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||